Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Revista Medica Del Instituto Mexicano Del Seguro Social|October 15, 2015
[Epigenetic alterations in cervical cancer progression]Magdalena Ríos-Romero, Ana Guadalupe Soto-Valladares, Patricia Piña-Sánchez
International Journal of Cancer|March 5, 2026
Long-term benefit from adjuvant tamoxifen therapy for ER+ HER2- breast cancer by PR positivityAnna E Nordenskjöld, Magdalena Ríos-Romero, Huma Dar, et al.
NPJ Breast Cancer|April 9, 2026
Stromal-based proteome data improve stratification of hormone receptor-positive breast cancerKenneth Finne, Silje Kjølle, Magdalena Ríos Romero, et al.
Scientific Reports|January 17, 2024
LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancerMireya Cisneros-Villanueva, Marco Antonio Fonseca-Montaño, Magdalena Ríos-Romero, et al.
Scientific Reports|August 6, 2020
A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtypeAlberto Cedro-Tanda, Magdalena Ríos-Romero, Sandra Romero-Córdoba, et al.
Scientific Reports|August 26, 2020
FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patientsMagdalena Ríos-Romero, Alberto Cedro-Tanda, Mónica Peña-Luna, et al.
Molecular Oncology|January 17, 2019
Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell deathFredy Omar Beltrán-Anaya, Sandra Romero-Córdoba, Rosa Rebollar-Vega, et al.
Frontiers in Oncology|April 29, 2021
LINC00460 Is a Dual Biomarker That Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related GenesMireya Cisneros-Villanueva, Lizbett Hidalgo-Pérez, Alberto Cedro-Tanda, et al.
Pageof 1